Page last updated: 2024-10-18

dalteparin and Fibrosis

dalteparin has been researched along with Fibrosis in 10 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to examine the effect of the antithrombotic drugs aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of liver cirrhosis and to determine if these two drugs are beneficial in animals with advanced fibrosis or with established cirrhosis undergoing partial hepatectomy."7.74The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. ( Assy, N; Hussein, O; Khalil, A; Luder, A; Paizi, M; Spira, G; Szvalb, S, 2007)
"The aim of this study was to examine the effect of the antithrombotic drugs aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of liver cirrhosis and to determine if these two drugs are beneficial in animals with advanced fibrosis or with established cirrhosis undergoing partial hepatectomy."3.74The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. ( Assy, N; Hussein, O; Khalil, A; Luder, A; Paizi, M; Spira, G; Szvalb, S, 2007)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's5 (50.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Gao, Z1
Li, S1
Zhao, J1
Li, J1
Gao, Y1
Spronk, HM1
De Jong, AM1
Verheule, S1
De Boer, HC1
Maass, AH1
Lau, DH1
Rienstra, M1
van Hunnik, A1
Kuiper, M1
Lumeij, S1
Zeemering, S1
Linz, D1
Kamphuisen, PW1
Ten Cate, H1
Crijns, HJ1
Van Gelder, IC1
van Zonneveld, AJ1
Schotten, U1
Diaz, JA1
Wrobleski, SK2
Alvarado, CM1
Hawley, AE2
Doornbos, NK1
Lester, PA1
Lowe, SE1
Gabriel, JE1
Roelofs, KJ1
Henke, PK3
Schaub, RG3
Wakefield, TW3
Myers, DD3
Ayata, M1
Kaptan, Z1
Uzunkulaoğlu, H1
Akyıldız, İ1
Tüzüner, A1
Ünverdi, H1
Karadaş, H1
Sood, V1
Luke, C1
Miller, E1
Mitsuya, M1
Upchurch, GR1
Emami, MJ1
Namazi, H1
Vosoughi, AR1
Nezhad, ST1
Oryan, A1
Mozaffarian, K1
Bedard, PW1
Kaila, N1
Shaw, G1
Meier, TR2
Assy, N1
Hussein, O1
Khalil, A1
Luder, A1
Szvalb, S1
Paizi, M1
Spira, G1
Baxi, S1
Crandall, DL1
Wrobleski, S1
Hawley, A1
Farris, D1
Elokdah, H1
Sigler, R1
Wakefield, T1
Myers, D1
Abe, W1
Ikejima, K1
Lang, T1
Okumura, K1
Enomoto, N1
Kitamura, T1
Takei, Y1
Sato, N1

Trials

1 trial available for dalteparin and Fibrosis

ArticleYear
Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
    Internal and emergency medicine, 2023, Volume: 18, Issue:2

    Topics: Albumins; Anticoagulants; Esophageal and Gastric Varices; Fibrosis; Gastrointestinal Hemorrhage; Hum

2023

Other Studies

9 other studies available for dalteparin and Fibrosis

ArticleYear
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
    European heart journal, 2017, 01-01, Volume: 38, Issue:1

    Topics: Analysis of Variance; Animals; Antithrombins; Atrial Fibrillation; Cell Proliferation; Dabigatran; F

2017
P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.
    Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:4

    Topics: Animals; Aptamers, Nucleotide; Blood Coagulation; Collagen; Disease Models, Animal; Enoxaparin; Fibr

2015
Effect of Enoxaparin Sodium on Experimentally-Induced Myringosclerosis in Rats.
    The journal of international advanced otology, 2015, Volume: 11, Issue:3

    Topics: Animals; Anticoagulants; Calcinosis; Disease Models, Animal; Enoxaparin; Fibrosis; Hyalin; Hyperemia

2015
Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
    Annals of vascular surgery, 2010, Volume: 24, Issue:2

    Topics: Animals; Disease Models, Animal; Doxycycline; Elasticity; Enoxaparin; Fibrin Fibrinogen Degradation

2010
Can enoxaparin prevent arthrofibrosis?
    International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:1

    Topics: Animals; Enoxaparin; Fibrinolytic Agents; Fibrosis; Joint Diseases; Knee Joint; Male; Orthopedic Pro

2012
Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.
    Journal of vascular surgery, 2006, Volume: 44, Issue:3

    Topics: Animals; Anticoagulants; Constriction, Pathologic; Disease Models, Animal; Enoxaparin; Fibrosis; Hyd

2006
The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:5

    Topics: Animals; Aspartate Aminotransferases; Aspirin; Bilirubin; Disease Progression; Enoxaparin; Fibrinoly

2007
Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:4

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enoxaparin; Fibrosis; Indoleaceti

2008
Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
    Journal of hepatology, 2007, Volume: 46, Issue:2

    Topics: Actins; Animals; Carbon Tetrachloride; Collagen Type I; Collagen Type I, alpha 1 Chain; Dalteparin;

2007